Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mitochondrial DNA in mice speeds up aging due to increased reactive oxygen species, not through the p53/p21 pathway.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Ten miRNAs may play key roles in starting secondary hair follicle development in sheep foetuses.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Acne treatment with isotretinoin increases the presence of p53, a protein, in skin and oil glands, which may help reduce acne severity.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Low vitamin D levels are common in people with Alopecia Areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Vitamin A affects hair loss and immune response in alopecia areata.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Activating β-catenin increases melanocytes and decreases Schwann cells.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Skin-derived precursors in hair follicles come from different origins but function similarly.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Gene network oscillations inside hair stem cells are key for hair growth regulation and could help treat hair loss.